Reciprocal upregulation of Notch signaling molecules in hematopoietic progenitor and mesenchymal stromal cells. 2011

Y Kikuchi, and A Kume, and M Urabe, and H Mizukami, and T Suzuki, and K Ozaki, and T Nagai, and K Ozawa
Division of Hematology, Department of Medicine, Jichi Medical University , Shimotsuke, Tochigi, Japan ; Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University , Shimotsuke, Tochigi, Japan.

Although mesenchymal stem cells (MSCs) play pivotal supportive roles in hematopoiesis, how they interact with hematopoietic stem cells (HSCs) is not well understood. We investigated the interaction between HSCs and surrogate MSCs (C3H10T1/2 stromal cells), focusing on the molecular events induced by cell contact of these bipartite populations. C3H10T1/2 is a mesenchymal stromal cell line that can be induced to differentiate into preadipocytes (A54) and myoblasts (M1601). The stromal cell derivatives were cocultured with murine HSCs (Lineage(-)Sca1(+)), and gene expression profiles in stromal cells and HSCs were compared before and after the coculture. HSCs gave rise to cobblestone areas only on A54 cells, with ninefold more progenitors than on M1601 or undifferentiated C3H10T1/2 cells. Microarray-based screening and a quantitative reverse transcriptase directed-polymerase chain reaction showed that the levels of Notch ligands (Jagged1 and Delta-like 3) were increased in A54 cells upon interaction with HSCs. On the other hand, the expression of Notch1 and Hes1 was upregulated in the HSCs cocultured with A54 cells. A transwell assay revealed that the reciprocal upregulation was dependent on cell-to-cell contact. The result suggested that in the hematopoietic niche, HSCs help MSCs to produce Notch ligands, and in turn, MSCs help HSCs to express Notch receptor. Such a reciprocal upregulation would reinforce the downstream signaling to determine the fate of hematopoietic cell lineage. Clarification of the initiating events on cell contact should lead to the identification of specific molecular targets to facilitate HSC engraftment in transplantation therapy.

UI MeSH Term Description Entries

Related Publications

Y Kikuchi, and A Kume, and M Urabe, and H Mizukami, and T Suzuki, and K Ozaki, and T Nagai, and K Ozawa
January 2007, Stem cells (Dayton, Ohio),
Y Kikuchi, and A Kume, and M Urabe, and H Mizukami, and T Suzuki, and K Ozaki, and T Nagai, and K Ozawa
January 1999, Leukemia & lymphoma,
Y Kikuchi, and A Kume, and M Urabe, and H Mizukami, and T Suzuki, and K Ozaki, and T Nagai, and K Ozawa
January 2008, Cells, tissues, organs,
Y Kikuchi, and A Kume, and M Urabe, and H Mizukami, and T Suzuki, and K Ozaki, and T Nagai, and K Ozawa
October 2022, Communications biology,
Y Kikuchi, and A Kume, and M Urabe, and H Mizukami, and T Suzuki, and K Ozaki, and T Nagai, and K Ozawa
November 2005, International journal of hematology,
Y Kikuchi, and A Kume, and M Urabe, and H Mizukami, and T Suzuki, and K Ozaki, and T Nagai, and K Ozawa
January 2015, PloS one,
Y Kikuchi, and A Kume, and M Urabe, and H Mizukami, and T Suzuki, and K Ozaki, and T Nagai, and K Ozawa
November 2003, Experimental cell research,
Y Kikuchi, and A Kume, and M Urabe, and H Mizukami, and T Suzuki, and K Ozaki, and T Nagai, and K Ozawa
June 2011, Experimental hematology,
Y Kikuchi, and A Kume, and M Urabe, and H Mizukami, and T Suzuki, and K Ozaki, and T Nagai, and K Ozawa
October 2011, Leukemia,
Y Kikuchi, and A Kume, and M Urabe, and H Mizukami, and T Suzuki, and K Ozaki, and T Nagai, and K Ozawa
January 2019, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!